Vaccines push Pfizer beyond expectations in final quarter

COVID-19 vaccine sales boosted Pfizer earnings well past expectations in the fourth quarter, but the drugmaker is setting a lower-than-expected bar for 2022.


You may also like

Brent crude oil

Brent crude oil

Crude oil

Crude oil